Rob has been advising on corporate finance transactions for over 14 years. He focuses on equity capital markets, frequently acting for issuers and banks on IPOs, follow-on offerings, takeovers, step-ups and general listed company transactions.
Rob also regularly advises on M&A transactions, acting for both private and public companies with a particular focus on cross-border transactions. Alongside the M&A transactions, Rob frequently advises on venture capital investments and shareholder arrangements.
Alongside the transactional matters, Rob also regularly advises on joint ventures and corporate partnerships both in the private and public sector. He is a member of our Boardroom Counsel group, frequently advising on ESG related matters and how to treat trust and reputation as a balance sheet asset.
Rob is an active member of DLA Piper’s Life Sciences sector, heading it up in the Birmingham office and a regular contributor to the Life Sciences Transactions site. Rob is also prominent in the real estate sector, commonly advising on joint venture and corporate structures through which real estate projects are established, developed and delivered.
Rob is a member of the London Stock Exchange’s Regional Advisory Group and an honorary lecturer at the University of Birmingham. Rob is chairman of DLA Piper’s UK events and campaigns workstream, ensuring our events are engaging, insightful and complementary with our go-to-market strategy. Rob also regularly volunteers and speaks at local incubators, offering pro bono advice to start-ups looking for a hand-up, particularly in the Life Sciences sector.
